The concentration operation consists of the acquisition by Palex Medical, S.A.U. (“Palex Medical”), a company ultimately controlled by Apax Partners LLP and Fremman Partners Limited, and integrated into the Palex Group, with exclusive control over Medicinália Cormédica-Mcmedical, Lda, (“Medicinália”), and Izasa Scientific, Lda, (“Izasa Scientific”).